SQZ Biotechnologies Current Ratio 2020-2023 | SQZ
SQZ Biotechnologies current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| SQZ Biotechnologies Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-03-31 |
$0.04B |
$0.01B |
3.50 |
| 2022-12-31 |
$0.07B |
$0.02B |
3.12 |
| 2022-09-30 |
$0.09B |
$0.03B |
3.46 |
| 2022-06-30 |
$0.11B |
$0.03B |
3.87 |
| 2022-03-31 |
$0.13B |
$0.03B |
4.34 |
| 2021-12-31 |
$0.15B |
$0.03B |
4.53 |
| 2021-09-30 |
$0.17B |
$0.04B |
4.25 |
| 2021-06-30 |
$0.19B |
$0.04B |
4.32 |
| 2021-03-31 |
$0.21B |
$0.04B |
4.98 |
| 2020-12-31 |
$0.18B |
$0.05B |
3.91 |
| 2020-09-30 |
$0.12B |
$0.05B |
2.35 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
